69
Participants
Start Date
April 1, 2021
Primary Completion Date
December 15, 2024
Study Completion Date
February 27, 2025
surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
Routine surgery after neoadjuvant chemotherapy for breast cancer according to current guidelines.
Immunohistochemistry Analysis
Determination of breast cancer subtypes through immunohistochemical analysis, and selection of Luminal B, HER2-positive, and triple-negative groups.
Second Biopsy
Taking biopsies from the center of the tumor and the peritumoral stroma of the same mass during marking of the mass before neoadjuvant chemotherapy
Haydarpasa Numune Training and Research Hospital, Istanbul
Haydarpasa Numune Training and Research Hospital
OTHER